CVRX INC. - COMMON ST

CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference

27 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

CVRx receives FDA approval for expanded labeling of Barostim

26 Dec 2023 07:05:00 By Nasdaq GlobeNewswire

CVRx to Present at the 35th Annual Piper Sandler Healthcare Conference

15 Nov 2023 15:21:43 By Nasdaq GlobeNewswire

CMS Increases Outpatient Payment for Barostim Procedure

03 Nov 2023 07:00:00 By Nasdaq GlobeNewswire

CVRx Reports Third Quarter 2023 Financial and Operating Results

26 Oct 2023 15:15:00 By Nasdaq GlobeNewswire

CVRx to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call on October 26th, 2023

12 Oct 2023 15:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the Canaccord Genuity 43rd Annual Growth Conference

27 Jul 2023 07:30:00 By Nasdaq GlobeNewswire

CVRx Reports Second Quarter 2023 Financial and Operating Results

25 Jul 2023 15:15:00 By Nasdaq GlobeNewswire

CVRx to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call on July 25th, 2023

11 Jul 2023 15:30:00 By Nasdaq GlobeNewswire

CVRx Set to Join Russell 2000 & 3000 Indexes

22 Jun 2023 15:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the William Blair 43rd Annual Growth Stock Conference

25 May 2023 07:30:00 By Nasdaq GlobeNewswire

CVRx Reports First Quarter 2023 Financial and Operating Results

27 Apr 2023 15:15:00 By Nasdaq GlobeNewswire

CVRx to Report First Quarter 2023 Financial and Operating Results and Host Conference Call on April 27th, 2023

20 Apr 2023 15:30:00 By Nasdaq GlobeNewswire

Totality of Evidence from BeAT-HF Study Shows CVRx’s Barostim Provides Long-term Benefits for Patients with Heart Failure

21 Mar 2023 10:02:23 By Nasdaq GlobeNewswire

CVRx Reiterates Plans to Discuss the Preliminary Results from the Post-Market Phase of the BeAT-HF Trial at THT 2023 and Schedules a Conference Call

16 Mar 2023 07:30:00 By Nasdaq GlobeNewswire

CVRx Reports Preliminary Results of the BeAT-HF Post-Market Randomized Clinical Trial

21 Feb 2023 06:00:00 By Nasdaq GlobeNewswire

CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

26 Jan 2023 15:15:00 By Nasdaq GlobeNewswire

CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

12 Jan 2023 16:30:00 By Nasdaq GlobeNewswire

CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

28 Dec 2022 07:30:00 By Nasdaq GlobeNewswire

CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors

20 Dec 2022 15:05:00 By Nasdaq GlobeNewswire